NRG1 and breast carcinoma: Comparing PDGFC expression across a broader range of breast cancer molecular subtypes, as well as evaluating the activity of the PDGFC/NRG1 signaling axis between tumor cells and fibroblasts, will provide valuable insights for the development of more precise therapeutic strategies in breast cancer.